Woman claims Biomet M2a Magnum hip implant forced her to endure pain, revision surgeriesNov 9, 2012
A woman claims her Biomet M2a Magnum™ metal-on-metal hip implants are defective and have caused her to suffer serious injuries and several painful revision surgeries. She has filed a lawsuit against the makers of the implants.
The woman claims that Biomet Inc. knowingly marketed its defective hip implants despite being aware that they had been linked to serious complications and could cause severe injuries. She is being represented in this lawsuit by the national law firm of Parker Waichman LLP, which represents numerous victims of defective metal-on-metal hip implants.
In this lawsuit, the woman being represented by the action claims to have received the Biomet M2a Magnum™ metal-on-metal hip implant in both her left and right hip joints. Soon after receiving the implants, the woman began experiencing severe pain and instability in both her hips. Both implants would often become dislocated and this required the victim to endure several painful revision surgeries.
Revision surgeries for defective metal-on-metal hip implants are costly and painful and may result in a loss of full mobility after enduring one, especially several.
The lawsuit claims the Biomet M2a Magnum™ hip implants were not properly tested for safety. Biomet Inc. and Biomet Orthopedics are named as Defendants in the Parker Waichman lawsuit. In an announcement of the lawsuit being filed in the U.S. District Court for the Middle District of Florida, the firm states, "Unlike other types of hip replacements, the M2a Magnum does not have the option of an acetabular cup liner."
This put this woman and many other recepients of the Biomet M2a Magnum hip implant at risk of suffering a dangerous complication, metallosis. The lack of that acetabular cup liner, the metal components of the hip implant rub together, spreading small metallic fragments through a recipient's body. If this goes unnoticed, a person many have toxic accumulations of the metals cobalt and chromium in their bloodstream. This can lead to organ and tissue damage and some reports indicate this specific complication may be responsible for small tumors growing in the body.
The lawsuit against Biomet is one of several filed by the law firm of Parker Waichman LLP. Like other suits before it, it claims the metal-on-metal hip implants were passed through the Food and Drug Adminsitration's flawed 510(k) "fast-track" approval system that grants clearance for medical devices that haven't been fully tested for safety simply because they mirror a design of another device.
In the case of the defective Biomet hip implant and other metal-on-metal hip implants, that design basis was likely flawed. Now, tens of thousands of people in the U.S. are currently depending on a metal-on-metal hip implant and could be at risk of suffering a similar fate.
In the meantime, the future of metal-on-metal hip implants is in serious jeopardy as makers of these devices have been asked to provide full safety profiles on their products to show they are safe and effective. With the rising number of complications linked to the devices, that data may be hard to produce.